Bharat Biotech International Limited is an Indian biotechnology company headquartered in Hyderabad, India engaged in thedrug discovery, drug development, manufacture of vaccines, bio-therapeutics, pharmaceuticals and health care products. Read More
Vaccination with Bharat Biotech's COVID-19 vaccine - COVAXIN, has produced neutralising titres (concentration) against all key emerging variants tested, including the B.1.617 and B.1.1.7, first identified in India and the United Kingdom, the vaccine ...
A public interest litigation has been moved in the Delhi High Court seeking direction to respondents to reduce the price of COVID vaccine for citizens. ...
Karnataka will soon have a manufacturing plant of Bharat Biotech's Covaxin in Maluru industrial area, near Kolara district, said Deputy Chief Minister and State COVID task force head Dr C N Ashwatha Narayana on Friday. ...
Amid the reports of vaccine shortage from various state, Central government and Hyderabad based Bharat Biotech is willing to invite other companies who want to produce COVAXIN to increase the production, said NITI Aayog member, Dr VK Paul, on Thursda ...
Amid the reports of shortage of Bharat Biotech's COVID-19 vaccine, the Centre on Wednesday said it will double the current production capacity of COVAXIN by May-June and then increase it to nearly six to seven folds by July-August. The government of ...
Andhra Pradesh YS Jaganmohan Reddy on Tuesday wrote to Prime Minister Narendra Modi seeking allocation of additional 320 metric tonnes (MT) of Liquid Medical Oxygen (LMO) and 20 tankers for oxygen supplies. ...
The Subject Expert Committee (SEC) has given a nod to Bharat Biotech's Covaxin for Phase 2 and 3 human clinical trials on children aged between two to eight years old, sources confirmed on Wednesday. ...
Delhi Chief Minister Arvind Kejriwal on Monday said that the national capital is preparing for the third wave of COVID-19 and the infrastructures are being scaled up to deal with 30,000 daily cases. ...
